ID   92-2
AC   CVCL_C300
SY   92_2; 92.2
DR   cancercelllines; CVCL_C300
DR   Cosmic; 916138
DR   Wikidata; Q54605665
RX   PubMed=7622289;
RX   PubMed=22383533;
CC   Sequence variation: Mutation; HGNC; 4390; GNAQ; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000375955; Zygosity=Heterozygous (PubMed=22383533).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8607 ! 92-1 [Human uveal melanoma]
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 13
//
RX   PubMed=7622289; DOI=10.1002/ijc.2910620208;
RA   De Waard-Siebinga I., Blom D.-J.R., Griffioen M., Schrier P.I.,
RA   Hoogendoorn E., Beverstock G.C., Danen E.H.J., Jager M.J.;
RT   "Establishment and characterization of an uveal-melanoma cell line.";
RL   Int. J. Cancer 62:155-161(1995).
//
RX   PubMed=22383533; DOI=10.1158/1535-7163.MCT-11-0676;
RA   Dutton-Regester K., Irwin D., Hunt P., Aoude L.G., Tembe V.,
RA   Pupo G.M., Lanagan C., Carter C.D., O'Connor L., O'Rourke M.,
RA   Scolyer R.A., Mann G.J., Schmidt C.W., Herington A., Hayward N.K.;
RT   "A high-throughput panel for identifying clinically relevant mutation
RT   profiles in melanoma.";
RL   Mol. Cancer Ther. 11:888-897(2012).
//